Industry Briefs: Mar. 19, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Bend Reasearch has launched a biotherapeutics-development initiative. Read More
OctoPlus has formed an agreement with a top-five generic-drugs company for the development of a formulation for an injectable drug. Read More
QRxPharma has signed a license and option agreement with Actavis. Read More
Recipharm has been contracted by ViroPharma to complete a full commercial scale-up manufacture of DuoCort’s Plenadren (hydrocortisone modified-release tablet). Read More
Shire plans to acquire FerroKin BioSciences for an upfront payment of $100 million. Read More
ThromboGenics has formed a commercialization agreement for Ocriplasmin with Alcon. Read More
People News
Stuart E. Needleman has been named president and chief operating officer of Aptuit, effective immediately. Read More
Avanir Pharmaceuticals has appointed Rohan Palekar as chief commercial officer. Read More
Unigene has appointed David Moskowitz as chief financial officer. Read More
